Parathyroid hormone and phosphate homeostasis in patients with Bartter and Gitelman syndrome: an international cross-sectional study.
Maartje F A VerploegenRosa Vargas-PoussouStephen B WalshHarika AlpayAtefeh AmouzegarGema AricetaBahriye AtmisJustine BacchettaPeter BárányStéphanie BaronUmut Selda BayrakciHendrica BelgeMartine BesouwAnne BlanchardArend BökenkampOlivia BoyerKathrin BurgmaierLorenzo A CalòStéphane DecramerOlivier DevuystMaria van DyckPietro Manuel FerraroMarc FilaTelma FranciscoGian Marco GhiggeriLeire GondraStefano GuarinoNakysa HoomanEwout J HoornPascal HouillierKonstantinos KamperisJameela A KariMartin KonradElena LevtchenkoLaura LucchettiFrancesca LuganiPierluigi MarzuilloBarian MohidinThomas J NeuhausAbdaldafae OsmanSvetlana PapizhManel PerellóMaarten B RookmaakerValerie Said ContiFernando SantosGhalia SawafErkin SerdarogluMaria SzczepanskaFrancesca TaroniRezan TopaloğluFrancesco TrepiccioneEnrico VidalElizabeth R WanLutz WeberZeynep Yuruk YildirimSelcuk YukselGalia ZlatanovaDetlef BockenhauerFrancesco EmmaTom NijenhuisPublished in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2022)
Hyperparathyroidism is frequent in patients with Bartter syndrome type I and II. Low serum phosphate is observed in a significant number of patients with Bartter and Gitelman syndrome and appears associated with renal phosphate wasting.
Keyphrases